• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid D

tetano

Editor, Senior Moderator
PLoS One. 2015 Aug 28;10(8):e0136539. doi: 10.1371/journal.pone.0136539. eCollection 2015.
[h=1]Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results.[/h] Shinjoh M[SUP]1[/SUP], Sugaya N[SUP]2[/SUP], Yamaguchi Y[SUP]3[/SUP], Tomidokoro Y[SUP]4[/SUP], Sekiguchi S[SUP]5[/SUP], Mitamura K[SUP]6[/SUP], Fujino M[SUP]7[/SUP], Shiro H[SUP]8[/SUP], Komiyama O[SUP]9[/SUP], Taguchi N[SUP]2[/SUP], Nakata Y[SUP]10[/SUP], Yoshida N[SUP]11[/SUP], Narabayashi A[SUP]12[/SUP], Myokai M[SUP]13[/SUP], Sato M[SUP]14[/SUP], Furuichi M[SUP]15[/SUP], Baba H[SUP]16[/SUP], Fujita H[SUP]17[/SUP], Sato A[SUP]18[/SUP], Ookawara I[SUP]19[/SUP], Tsunematsu K[SUP]20[/SUP], Yoshida M[SUP]21[/SUP], Kono M[SUP]22[/SUP], Tanaka F[SUP]23[/SUP], Kawakami C[SUP]24[/SUP], Kimiya T[SUP]4[/SUP], Takahashi T[SUP]5[/SUP], Iwata S[SUP]25[/SUP]; Keio Pediatric Influenza Research Group.
[h=3]Author information[/h]

[h=3]Abstract[/h] We assessed vaccine effectiveness (VE) against medically attended, laboratory-confirmed influenza in children 6 months to 15 years of age in 22 hospitals in Japan during the 2013-14 season. Our study was conducted according to a test-negative case-control design based on influenza rapid diagnostic test (IRDT) results. Outpatients who came to our clinics with a fever of 38?C or over and had undergone an IRDT were enrolled in this study. Patients with positive IRDT results were recorded as cases, and patients with negative results were recorded as controls. Between November 2013 and March 2014, a total of 4727 pediatric patients (6 months to 15 years of age) were enrolled: 876 were positive for influenza A, 66 for A(H1N1)pdm09 and in the other 810 the subtype was unknown; 1405 were positive for influenza B; and 2445 were negative for influenza. Overall VE was 46% (95% confidence interval [CI], 39-52). Adjusted VE against influenza A, influenza A(H1N1)pdm09, and influenza B was 63% (95% CI, 56-69), 77% (95% CI, 59-87), and 26% (95% CI, 14-36), respectively. Influenza vaccine was not effective against either influenza A or influenza B in infants 6 to 11 months of age. Two doses of influenza vaccine provided better protection against influenza A infection than a single dose did. VE against hospitalization influenza A infection was 76%. Influenza vaccine was effective against influenza A, especially against influenza A(H1N1)pdm09, but was much less effective against influenza B.


PMID: 26317334 [PubMed - in process] Free full text
 
Back
Top Bottom